Platzbecker, U., Wermke, M., Radke, J., Oelschlaegel, U., Seltmann, F., Kiani, A., . . . Thiede, C. (2012). Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: Results of the RELAZA trial. Nature Publishing Group.
Chicago Stili AlıntıPlatzbecker, U., et al. Azacitidine for Treatment of Imminent Relapse in MDS or AML Patients After Allogeneic HSCT: Results of the RELAZA Trial. Nature Publishing Group, 2012.
MLA AlıntıPlatzbecker, U., et al. Azacitidine for Treatment of Imminent Relapse in MDS or AML Patients After Allogeneic HSCT: Results of the RELAZA Trial. Nature Publishing Group, 2012.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..